MedPath

Evaluation for the effectiveness of Sacubitril-valsartan for acute type B aortic dissection.

Not Applicable
Conditions
Acute type B aortic dissection
Registration Number
JPRN-UMIN000046000
Lead Sponsor
Kawasaki Medical School General Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Complicated cases necessitate emergent or urgent surgery, patients with dialysis, patients who cannot take medicine orally, patients who cannot accept the informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We evaluate the change of renal function during the conservative treatment of aortic dissection for a week after the onset. Blood tests and urine samples will be evaluated.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath